Skip to main content
Top
Published in: Journal of Nuclear Cardiology 5/2021

01-10-2021 | Abdominal Aortic Aneurysm | Editorial

Optimizing arterial 18F-sodium fluoride positron emission tomography analysis

Authors: Jamie W. Bellinge, MBBS, Carl J. Schultz, MD, PhD

Published in: Journal of Nuclear Cardiology | Issue 5/2021

Login to get access

Excerpt

Cardiovascular disease (CVD) remains a leading cause of death worldwide and methods to improve risk stratification and prevention are required. Non-invasive imaging plays an important role in CVD risk stratification, for example the use of CT-coronary calcium scoring to reclassify patients deemed at intermediate risk based on clinical risk scores. However, the quantification of plaque burden often does not distinguish patients with quiescent disease from those who will go on to develop worsening disease manifesting in a cardiovascular disease event. An attractive feature of molecular imaging modalities is the potential to detect and localize active pathophysiological processes that drive progressive vascular disease and subsequent clinical events. …
Literature
1.
go back to reference Chaikof EL, Dalman RL, Eskandari MK, Jackson BM, Lee WA, Mansour MA, et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg 2018;67:e2.CrossRef Chaikof EL, Dalman RL, Eskandari MK, Jackson BM, Lee WA, Mansour MA, et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg 2018;67:e2.CrossRef
2.
go back to reference Parkinson F, Ferguson S, Lewis P, Williams IM, Twine CP. Rupture rates of untreated large abdominal aortic aneurysms in patients unfit for elective repair. J Vasc Surg 2015;61:1606-12.CrossRef Parkinson F, Ferguson S, Lewis P, Williams IM, Twine CP. Rupture rates of untreated large abdominal aortic aneurysms in patients unfit for elective repair. J Vasc Surg 2015;61:1606-12.CrossRef
3.
go back to reference Couto E, Duffy SW, Ashton HA, Walker NM, Myles JP, Scott RA, et al. Probabilities of progression of aortic aneurysms: Estimates and implications for screening policy. J Med Screen 2002;9:40-2.CrossRef Couto E, Duffy SW, Ashton HA, Walker NM, Myles JP, Scott RA, et al. Probabilities of progression of aortic aneurysms: Estimates and implications for screening policy. J Med Screen 2002;9:40-2.CrossRef
4.
go back to reference Forsythe RO, Dweck MR, McBride OM, Vesey AT, Semple SI, Shah AS, et al. 18F-sodium fluoride uptake in abdominal aortic aneurysms. J Am Coll Cardiol 2018;71:513-23.CrossRef Forsythe RO, Dweck MR, McBride OM, Vesey AT, Semple SI, Shah AS, et al. 18F-sodium fluoride uptake in abdominal aortic aneurysms. J Am Coll Cardiol 2018;71:513-23.CrossRef
6.
go back to reference Irkle A, Vesey AT, Lewis DY, Skepper JN, Bird JL, Dweck MR, et al. Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat Commun 2015;6:7495.CrossRef Irkle A, Vesey AT, Lewis DY, Skepper JN, Bird JL, Dweck MR, et al. Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat Commun 2015;6:7495.CrossRef
7.
go back to reference Joshi NV, Vesey AT, Williams MC, Shah AS, Calvert PA, Craighead FH, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: A prospective clinical trial. Lancet 2014;383:705-13.CrossRef Joshi NV, Vesey AT, Williams MC, Shah AS, Calvert PA, Craighead FH, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: A prospective clinical trial. Lancet 2014;383:705-13.CrossRef
8.
go back to reference Lee JM, Bang J-I, Koo B-K, Hwang D, Park J, Zhang J, et al. Clinical relevance of (18)F-sodium fluoride positron-emission tomography in noninvasive identification of high-risk plaque in patients with coronary artery disease. Circ Cardiovasc Imaging 2017;10:e006704.CrossRef Lee JM, Bang J-I, Koo B-K, Hwang D, Park J, Zhang J, et al. Clinical relevance of (18)F-sodium fluoride positron-emission tomography in noninvasive identification of high-risk plaque in patients with coronary artery disease. Circ Cardiovasc Imaging 2017;10:e006704.CrossRef
9.
go back to reference Vesey AT, Jenkins WS, Irkle A, Moss A, Sng G, Forsythe RO, et al. 18F-fluoride and 18F-fluorodeoxyglucose positron emission tomography after transient ischemic attack or minor ischemic stroke. Circ Cardiovasc Imaging 2017;10:e004976.CrossRef Vesey AT, Jenkins WS, Irkle A, Moss A, Sng G, Forsythe RO, et al. 18F-fluoride and 18F-fluorodeoxyglucose positron emission tomography after transient ischemic attack or minor ischemic stroke. Circ Cardiovasc Imaging 2017;10:e004976.CrossRef
10.
go back to reference Dweck MR, Jenkins WS, Vesey AT, Pringle MA, Chin CW, Malley TS, et al. 18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis. Circ Cardiovasc Imaging 2014;7:371-8.CrossRef Dweck MR, Jenkins WS, Vesey AT, Pringle MA, Chin CW, Malley TS, et al. 18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis. Circ Cardiovasc Imaging 2014;7:371-8.CrossRef
11.
go back to reference Alavi A, Werner TJ, Høilund-Carlsen PF. What can be and what cannot be accomplished with PET to detect and characterize atherosclerotic plaques. J Nucl Cardiol 2018;25:2012-5.CrossRef Alavi A, Werner TJ, Høilund-Carlsen PF. What can be and what cannot be accomplished with PET to detect and characterize atherosclerotic plaques. J Nucl Cardiol 2018;25:2012-5.CrossRef
12.
go back to reference Bellinge JW, Francis RJ, Majeed K, Watts GF, Schultz CJ. In search of the vulnerable patient or the vulnerable plaque: 18F-sodium fluoride positron emission tomography for cardiovascular risk stratification. J Nucl Cardiol 2018;25:1774-83.CrossRef Bellinge JW, Francis RJ, Majeed K, Watts GF, Schultz CJ. In search of the vulnerable patient or the vulnerable plaque: 18F-sodium fluoride positron emission tomography for cardiovascular risk stratification. J Nucl Cardiol 2018;25:1774-83.CrossRef
14.
go back to reference Moss AJ, Doris MK, Andrews JP, Bing R, Daghem M, van Beek EJ, et al. Molecular coronary plaque imaging using 18F-fluoride. Circ Cardiovasc Imaging 2019;12:1-11.CrossRef Moss AJ, Doris MK, Andrews JP, Bing R, Daghem M, van Beek EJ, et al. Molecular coronary plaque imaging using 18F-fluoride. Circ Cardiovasc Imaging 2019;12:1-11.CrossRef
15.
go back to reference Doris MK, Rubeaux M, Pawade T, Otaki Y, Xie Y, Li D, et al. Motion-corrected imaging of the aortic valve with 18F-NaF PET/CT and PET/MRI: A feasibility study. J Nucl Med 2017;58:1811-4.CrossRef Doris MK, Rubeaux M, Pawade T, Otaki Y, Xie Y, Li D, et al. Motion-corrected imaging of the aortic valve with 18F-NaF PET/CT and PET/MRI: A feasibility study. J Nucl Med 2017;58:1811-4.CrossRef
18.
go back to reference Cal-Gonzalez J, Li X, Heber D, Rausch I, Moore SC, Schäfers K, et al. Partial volume correction for improved PET quantification in 18F-NaF imaging of atherosclerotic plaques. J Nucl Cardiol 2018;25:1742-56.CrossRef Cal-Gonzalez J, Li X, Heber D, Rausch I, Moore SC, Schäfers K, et al. Partial volume correction for improved PET quantification in 18F-NaF imaging of atherosclerotic plaques. J Nucl Cardiol 2018;25:1742-56.CrossRef
19.
go back to reference Lassen ML, Kwiecinski J, Cadet S, Dey D, Wang C, Dweck MR, et al. Data-driven gross patient motion detection and compensation: Implications for coronary 18F-NaF PET imaging. J Nucl Med 2019;60:830-6.CrossRef Lassen ML, Kwiecinski J, Cadet S, Dey D, Wang C, Dweck MR, et al. Data-driven gross patient motion detection and compensation: Implications for coronary 18F-NaF PET imaging. J Nucl Med 2019;60:830-6.CrossRef
20.
go back to reference Lassen ML, Kwiecinski J, Dey D, Cadet S, Germano G, Berman DS, et al. Triple-gated motion and blood pool clearance corrections improve reproducibility of coronary 18F-NaF PET. Eur J Nucl Med Mol Imaging 2019;46:2610-20.CrossRef Lassen ML, Kwiecinski J, Dey D, Cadet S, Germano G, Berman DS, et al. Triple-gated motion and blood pool clearance corrections improve reproducibility of coronary 18F-NaF PET. Eur J Nucl Med Mol Imaging 2019;46:2610-20.CrossRef
Metadata
Title
Optimizing arterial 18F-sodium fluoride positron emission tomography analysis
Authors
Jamie W. Bellinge, MBBS
Carl J. Schultz, MD, PhD
Publication date
01-10-2021
Publisher
Springer International Publishing
Published in
Journal of Nuclear Cardiology / Issue 5/2021
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-019-01992-6

Other articles of this Issue 5/2021

Journal of Nuclear Cardiology 5/2021 Go to the issue